Latest CSL Limited Stories
CSL Plasma center openings are on the rise, as is the demand for plasma protein therapies for the treatment of rare and serious diseases. KING OF PRUSSIA, Pa., Oct.
Company further increases global manufacturing capabilities with production expansions of albumin in Australia and plasma intermediates in U.S.
The 140,000-square foot expansion has received regulatory approval from the U.S. Food & Drug Administration. KING OF PRUSSIA, Pa., Sept.
CSL Behring Assists The Jeffrey Modell Foundation and National Association of School Nurses to prepare an information blitz to improve early referral and diagnosis. KING OF PRUSSIA, Pa., Aug.
Findings presented at the 2014 World Transplant Congress SAN FRANCISCO, July 30, 2014 /PRNewswire/ -- A study presented at the 2014 World Transplant Congress evaluated the safety and
Interlaken Leadership Awards Program Supports Original Research in the Field of Neuroimmunology KING OF PRUSSIA, Pa., June 24, 2014 /PRNewswire/ --
Eligible Participants to Receive Payment Assistance with Out-of-Pocket Costs Associated with Hizentra® Therapy in the United States KING OF PRUSSIA, Pa., May 20, 2014 /PRNewswire/
Third annual awareness day shines a light on rare, potentially life-threatening condition KING OF PRUSSIA, Pa., May 14, 2014 /PRNewswire/ -- As a Diamond Sponsor of HAE Day on May 16, 2014,
Data showing improved pharmacokinetic profile to be presented at World Federation of Hemophilia Congress MELBOURNE, Australia, May 11, 2014 /PRNewswire/ -- Interim Phase II/III and
-- Leading-edge science at the core of $250 million expansion to drive long-term growth in promising bleeding disorders portfolio KING OF PRUSSIA, Pa., May 9, 2014 /PRNewswire/
- a meat pie that is usually eaten at Christmas in Quebec